Dawnrays Pharmaceutical (Holdings) Limited

Dawnrays Pharmaceutical (Holdings) Limitedverified

2348.HK

Price:

$1.21

Market Cap:

$1.65B

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2003-07-11

Stock Exchange

HKSE

Ticker

2348.HK

The Enterprise Value as of December 2025 (TTM) for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) is 516.20M

According to Dawnrays Pharmaceutical (Holdings) Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 516.20M. This represents a change of -19.90% compared to the average of 644.41M of the last 4 quarters.

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) Historical Enterprise Value (quarterly & annually)

How has 2348.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Dawnrays Pharmaceutical (Holdings) Limited over the last ten years is 1.62B. The current 516.20M Enterprise Value has changed 3.08% with respect to the historical average. Over the past ten years (40 quarters), 2348.HK's Enterprise Value was at its highest in in the June 2015 quarter at 3.89B. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Quarterly (TTM)
Annual

Average

1.62B

Median

1.44B

Minimum

601.73M

Maximum

3.37B

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dawnrays Pharmaceutical (Holdings) Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 35.86%

Maximum Annual Enterprise Value = 3.37B

Minimum Annual Increase = -38.02%

Minimum Annual Enterprise Value = 601.73M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024601.73M-8.50%
2023657.61M-31.26%
2022956.61M-35.47%
20211.48B35.86%
20201.09B-38.02%
20191.76B25.65%
20181.40B-36.78%
20172.22B-17.69%
20162.69B-20.20%
20153.37B25.55%

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) Average Enterprise Value

How has 2348.HK Enterprise Value performed in the past?

The current Enterprise Value of Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

738.65M

5-year avg

957.94M

10-year avg

1.62B

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) Enterprise Value vs. Peers

How is 2348.HK’s Enterprise Value compared to its peers?

Dawnrays Pharmaceutical (Holdings) Limited’s Enterprise Value is greater than Chia Tai Enterprises International Limited (244.78M), less than Chaoju Eye Care Holdings Limited (1.62B), less than Jilin Province Huinan Changlong Bio-pharmacy Company Limited (718.16M), less than JBM (Healthcare) Limited (2.35B), less than Lee's Pharmaceutical Holdings Limited (923.41M), less than Essex Bio-Technology Limited (1.81B), less than Rici Healthcare Holdings Limited (2.57B), less than Zhaoke Ophthalmology Limited (763.15M), less than Golden Throat Holdings Group Company Limited (1.78B), less than Sipai Health Technology Co., Ltd. (1.39B),

Build a custom stock screener for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dawnrays Pharmaceutical (Holdings) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dawnrays Pharmaceutical (Holdings) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Dawnrays Pharmaceutical (Holdings) Limited's Enterprise Value?

What is the highest Enterprise Value for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)?

What is the 3-year average Enterprise Value for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)?

What is the 5-year average Enterprise Value for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)?

How does the current Enterprise Value for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) compare to its historical average?